The phosphatase and tensin homolog (PTEN) tumour suppressor gene, amongst others, is a negative regulator of the PI3K pathway and is often lost in BC [4], leading to enhanced activation of AKT and downstream partners. The gene discussed is PTEN; the disease is breast cancer.